LRRK2 and Parkinson disease: In addition, overexpression of miR-205 in cultured primary neural cells improved neurite outgrowth of neurons expressing a mutant LRRK2, R1441G, indicating that miR-205 may be used as the therapeutic target to suppress the abnormal upregulation of LRRK2 protein in PD (Cho et al., 2013).